Hungaropharma Sustainability Profile
Hungaropharma Zrt., a leading player in the pharmaceutical distribution industry, is headquartered in Hungary (HU) and operates extensively across Central and Eastern Europe. Founded in 1991, the company has established itself as a trusted partner in the healthcare sector, focusing on the distribution of pharmaceuticals, medical devices, and healthcare products. With a commitment to quality and innovation, Hungaropharma offers a diverse range of services, including logistics and supply chain management tailored to the needs of healthcare providers. The company is recognised for its robust market position, serving a wide network of pharmacies, hospitals, and healthcare institutions. Notable achievements include significant growth in operational capacity and strategic partnerships that enhance its service offerings, solidifying Hungaropharma's reputation as a cornerstone of the pharmaceutical landscape in the region.
DitchCarbon Score
How does Hungaropharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hungaropharma's score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hungaropharma's reported carbon emissions
Hungaropharma currently does not have available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges that the company has committed to at this time. Without emissions data or reduction initiatives, it is challenging to assess their climate commitments or performance within the industry context. As such, Hungaropharma's current stance on carbon emissions and climate action remains unclear.
How Carbon Intensive is Hungaropharma's Industry?
How Carbon Intensive is Hungaropharma's Location?
Hungaropharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hungaropharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Walgreens Boots Alliance
Boehringer Ingelheim Pharmaceuticals, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.